BOMYNTRA FDA approval date

The FDA approved BOMYNTRA on 25 Mar 2025.

FDA approval date
25 Mar 2025

Drug identity has not yet been verified against registry records

Also recorded as DENOSUMAB-BNHT

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2025-03-25DayBOMYNTRAFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA761398", "applicant_as_listed_by_fda": "FRESENIUS KABI USA LLC", "brand_names": ["BOMYNTRA", "CONEXXENCE"], "active_ingredients": ["DENOSUMAB-BNHT"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20250325", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026